Compare IDEXX Laboratories, Inc. (IDXX) vs Invesco S&P 500 Low Volatility ETF (SPLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Invesco S&P 500 Low Volatility ETF — how do they compare? IDEXX Laboratories, Inc. trades at $572.01 (market cap $44.95B), while Invesco S&P 500 Low Volatility ETF trades at $75.6. The key difference: Invesco S&P 500 Low Volatility ETF is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | SPLV | |
|---|---|---|
Market Cap | $44.95B | — |
Sector | Health | — |
52-Week High | $766.68 | $77.97 |
52-Week Low | $526.44 | $70.30 |
Enterprise Value | $45.85B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $570.58, down 4.23% over 24 hours, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $4.27 surpassing the $3.94 expectation. Revenue growth remains robust, supported by a 74.21% ROE and expanding diagnostic offerings. Recent news highlights product expansion, including a dual-species cardiac test, reinforcing its market leadership in veterinary diagnostics.
The outlook is positive, driven by durable competitive advantages and international growth potential. However, elevated valuation multiples and competitive pressures pose risks. Analyst consensus is bullish with a $683.33 price target, suggesting significant upside from current levels, though investors should monitor execution on guidance and macroeconomic headwinds.
SPLV trades at $75.82, up 0.16% with a bullish technical signal supported by moving averages. The ETF provides exposure to 100 S&P 500 stocks with the lowest volatility, maintaining $6.93 billion in assets and a history of minimal calendar-year losses exceeding 5%. Recent dividend payments of $0.14 demonstrate consistent income distribution to shareholders.
Low-volatility ETFs like SPLV gain appeal during market uncertainty, offering defensive positioning amid geopolitical tensions and inflation concerns. The fund's quarterly reconstitution and focus on stable large-caps provide resilience, though concentration in low-volatility sectors may limit upside during strong bull markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Invesco S&P 500 Low Volatility ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the "index Provider") compiles, maintains and calculates the underlying index, which is designed to measure the performance of the 100 least volatile constituents of the S&P 500 ® Index over the past 12 months as determined by the index Provider.
Read more on SPLV →
